Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Eli Lilly (NY: LLY ) 924.56 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Sep 25, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 10,382 Open 924.56 Bid (Size) 924.44 (3) Ask (Size) 926.20 (1) Prev. Close 924.56 Today's Range 924.56 - 924.56 52wk Range 516.57 - 972.53 Shares Outstanding N/A Dividend Yield 0.49% Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Is NYSE:LLY a Fit for high Growth Investing Strategies? Today 6:20 EDT Exploring ELI LILLY & CO (NYSE:LLY)'s high growth characteristics. Via Chartmill Novo Nordisk's $600 Million Gambit Could Be a Game Changer for the Stock. Here's Why. Today 5:40 EDT The healthcare company's pivot into a new set of technologies will have many implications for the stock. Via The Motley Fool Performance YTD +56.12% +56.12% 1 Month -2.73% -2.73% 3 Month +2.59% +2.59% 6 Month +18.81% +18.81% 1 Year +68.10% +68.10% More News Read More Eli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments September 25, 2024 Via Benzinga Popular Ozempic May Have New Use As Semaglutide Drugs Linked To Reduced Overdose Risk In Diabetic Opioid Users September 25, 2024 Via Benzinga Can Novo Nordisk's Weight Loss Drug Ozempic Help Stem The Devastating Addiction Crisis? New Research Says Yes September 25, 2024 Via Benzinga Eli Lilly Unusual Options Activity September 25, 2024 Via Benzinga $1000 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today September 24, 2024 Via Benzinga Spotlight on Eli Lilly: Analyzing the Surge in Options Activity September 23, 2024 Via Benzinga In-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry September 20, 2024 Via Benzinga Amgen's Rocatinlimab Has Commercial Potential Despite Competitive Landscape, Says Goldman Sachs September 25, 2024 Via Benzinga Eli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years September 25, 2024 Via Benzinga Exposures Product Safety Why This Stock Could Be the Nvidia of Healthcare September 25, 2024 Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges September 24, 2024 Via MarketBeat Eli Lilly's Early Alzheimer's Treatment Donanemab Scores Japanese Approval, Its Second Largest Market September 24, 2024 Via Benzinga As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse September 24, 2024 Via FinancialNewsMedia Exposures Product Safety As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse September 24, 2024 From FN Media Group LLC Via GlobeNewswire Investing in This Healthcare Stock Could Be Like Catching Nvidia at the Dawn of the AI Boom September 22, 2024 Via The Motley Fool Topics Artificial Intelligence Exposures Artificial Intelligence Prediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split) September 21, 2024 Via The Motley Fool Netflix, Eli Lilly Lead 5 Fast Growers Near Buy Points September 21, 2024 Via Investor's Business Daily Why Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today September 20, 2024 Via The Motley Fool US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices September 20, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Eli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules September 20, 2024 Via Benzinga Topics Fraud Exposures Legal Why Tandem Diabetes Care Stock Thrashed the Market Today September 19, 2024 Via The Motley Fool 2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure? September 19, 2024 Via Investor's Business Daily 1 Unstoppable Stock That Could Join the $1 Trillion Club in 2025 September 19, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.